Shijiazhuang Yiling Pharmaceutical Co,Ltd.
News
Home - News
News

lianhua qingwen capsule clinical application

lianhua qingwen capsule clinical application
• Collected By National Essential Medicine Catalogue
• Collected By National Basic Medical Insurance Category
• National-level Key New Product
• Conferred with Second Prize of National Scientific and Technological Progress
• 2005, recommended medicine from“Human Avian Flu Diagnosis and Treatment Program” issued by National Ministry of Health.
• 2009, recommended medicine from “Human Infected with Influenza A H1N1 Diagnosis and Treatment Program“ issued by National Ministry of Health.
• 2011, “Guide for Diagnosis and Treatment of Influenza” issued by National Ministry of Health.
• 2013, 2014, 2017, recommended medicine from “Human Infected with H7N9 Avian Flu Diagnosis and Treatment Program”issued by National Health and Family Planning Commission.
• 2018, recommended medicine from “Diagnosis and Treatment Program of Influenza” issued by National Health and Family Planning Commission.
• 2015, recommended medicine from“Middle East Respiratory Syndrome Case Diagnosis and Treatment Program” issued by National Health and Family Planning Commission.
Pharmacological and clinical studies have confirmed: Lianhua Qingwen has efficacy of broad-spectrum anti-virus and anti-bacterial. It has exact efficacy in clinical treating colds, influenza, rhinitis and laryngitis, as well as assist in improving lung infection.
【Clinical Application】
• Broad-spectrum anti-virus, anti-influenza A virus H1N1 & H3N2, avian influenza H5N1 & H9N2, SARS, EV71 virus.
• Defervescence, relieve cough, dissolve phlegm, diminish inflammation, and quickly eliminate cold symptoms.
• Increase immunity and improve resistance and recovery.
【Dosage】Take orally, 4 capsules/time, 3 times/day.
【Specification】0.35g/capsule.
【Packing】Blister package, 24 capsules/box, 400boxes/carton.

【MA Number】License of State Drug Administration Z20040063.

lianhua qingwen capsule




Next: No more!!